FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3037044462> ?p ?o ?g. }

• W3037044462 endingPage "42" @default.
• W3037044462 startingPage "35" @default.
• W3037044462 abstract "Beside the pulmonary vasoconstriction observed in pulmonary arterial hypertension (PAH), severe proliferative and antiapoptotic cellular phenotypes result in vascular remodelling. Many recent findings indicate similarities between PAH and tumour pathology. For instance, insulin-like growth factor (IGF)-1 signalling, which is known to promote tumour development, is implicated in PAH. Higher circulating IGF binding protein (IGFBP)-1 levels are associated with worse survival in PAH. The present study aimed to investigate the relationship between plasma levels of various tumour-related biomarkers and PAH. Methods: IGFBP-1, -2 and -7, along with other tumour-related biomarkers, were measured in plasma from 48 treatment-naïve PAH patients and 16 healthy controls, using proximity extension assays. Among the PAH patients, 33 were also studied at an early treatment follow-up. Results: Plasma IGFBP-1 (p < .003), IGFBP-2 (p < .001), IGFBP-7 (p < .008), vimentin (p < .001), carbonic anhydrase 9 (p < .001), S100A11 (p < .001), human epididymis protein 4 (p < .001) and folate receptor-α (p < .004) were elevated in PAH, compared to controls. IGFBP-1 exhibited the most interesting correlations to clinical parameters and was selected for further analyses. IGFBP-1 correlated specifically to N-terminal prohormone of brain natriuretic peptide (NT-proBNP) (r = 0.44, p < .002), mean right atrial pressure (r = 0.41, p < .004), venous oxygen saturation (r = -0.43, p < .003), cardiac index (r = -0.32, p < .03) and 6-minute walking distance (r = -0.29, p < .05). Plasma IGFBP-1 also correlated to risk scores based on the European Society of Cardiology/European Respiratory Society (ESC/ERS) PAH guidelines (r = 0.43, p < .003) and the REVEAL model (r = 0.46, p < .001). PAH patients with supra-median baseline IGFBP-1 levels showed a trend for worse overall survival than those with infra-median levels (p = .087). IGFBP-1 was unaltered between baseline and an early treatment follow-up. However, IGFBP-1 changes, between baseline and follow-up, correlated to changes in NT-proBNP (r = 0.48, p < .006). Conclusion: Plasma IGFBP-1 levels at PAH diagnosis show moderate association to NT-proBNP and hemodynamics as well as with ESC/ERS and REVEAL risk scores." @default.
• W3037044462 created "2020-07-02" @default.
• W3037044462 creator A5026915556 @default.
• W3037044462 creator A5051407972 @default.
• W3037044462 creator A5065839491 @default.
• W3037044462 date "2020-06-29" @default.
• W3037044462 modified "2023-09-26" @default.
• W3037044462 title "Plasma insulin-like growth factor binding protein 1 in pulmonary arterial hypertension" @default.
• W3037044462 cites W1995097523 @default.
• W3037044462 cites W1998875485 @default.
• W3037044462 cites W2000457934 @default.
• W3037044462 cites W2003108870 @default.
• W3037044462 cites W2010084870 @default.
• W3037044462 cites W2018811956 @default.
• W3037044462 cites W2041507819 @default.
• W3037044462 cites W2077065151 @default.
• W3037044462 cites W2089812396 @default.
• W3037044462 cites W2098368231 @default.
• W3037044462 cites W2098685167 @default.
• W3037044462 cites W2114374604 @default.
• W3037044462 cites W2117692326 @default.
• W3037044462 cites W2125452298 @default.
• W3037044462 cites W2130661187 @default.
• W3037044462 cites W2139960175 @default.
• W3037044462 cites W2161370807 @default.
• W3037044462 cites W2162865304 @default.
• W3037044462 cites W2167165074 @default.
• W3037044462 cites W2167283625 @default.
• W3037044462 cites W2188274912 @default.
• W3037044462 cites W2223535266 @default.
• W3037044462 cites W2302884175 @default.
• W3037044462 cites W2345789811 @default.
• W3037044462 cites W2420074592 @default.
• W3037044462 cites W2501807035 @default.
• W3037044462 cites W2517957586 @default.
• W3037044462 cites W2592714610 @default.
• W3037044462 cites W2621229357 @default.
• W3037044462 cites W2623733031 @default.
• W3037044462 cites W2626672968 @default.
• W3037044462 cites W2775867617 @default.
• W3037044462 cites W2885921501 @default.
• W3037044462 cites W2887613806 @default.
• W3037044462 cites W2900544195 @default.
• W3037044462 doi "https://doi.org/10.1080/14017431.2020.1782977" @default.
• W3037044462 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32597241" @default.
• W3037044462 hasPublicationYear "2020" @default.
• W3037044462 type Work @default.
• W3037044462 sameAs 3037044462 @default.
• W3037044462 citedByCount "6" @default.
• W3037044462 countsByYear W30370444622021 @default.
• W3037044462 countsByYear W30370444622022 @default.
• W3037044462 countsByYear W30370444622023 @default.
• W3037044462 crossrefType "journal-article" @default.
• W3037044462 hasAuthorship W3037044462A5026915556 @default.
• W3037044462 hasAuthorship W3037044462A5051407972 @default.
• W3037044462 hasAuthorship W3037044462A5065839491 @default.
• W3037044462 hasBestOaLocation W30370444621 @default.
• W3037044462 hasConcept C126322002 @default.
• W3037044462 hasConcept C134018914 @default.
• W3037044462 hasConcept C147447768 @default.
• W3037044462 hasConcept C170493617 @default.
• W3037044462 hasConcept C204232928 @default.
• W3037044462 hasConcept C2775846464 @default.
• W3037044462 hasConcept C2775915353 @default.
• W3037044462 hasConcept C2775960820 @default.
• W3037044462 hasConcept C2778198053 @default.
• W3037044462 hasConcept C2780090379 @default.
• W3037044462 hasConcept C2780378035 @default.
• W3037044462 hasConcept C2780689927 @default.
• W3037044462 hasConcept C71315377 @default.
• W3037044462 hasConcept C71924100 @default.
• W3037044462 hasConceptScore W3037044462C126322002 @default.
• W3037044462 hasConceptScore W3037044462C134018914 @default.
• W3037044462 hasConceptScore W3037044462C147447768 @default.
• W3037044462 hasConceptScore W3037044462C170493617 @default.
• W3037044462 hasConceptScore W3037044462C204232928 @default.
• W3037044462 hasConceptScore W3037044462C2775846464 @default.
• W3037044462 hasConceptScore W3037044462C2775915353 @default.
• W3037044462 hasConceptScore W3037044462C2775960820 @default.
• W3037044462 hasConceptScore W3037044462C2778198053 @default.
• W3037044462 hasConceptScore W3037044462C2780090379 @default.
• W3037044462 hasConceptScore W3037044462C2780378035 @default.
• W3037044462 hasConceptScore W3037044462C2780689927 @default.
• W3037044462 hasConceptScore W3037044462C71315377 @default.
• W3037044462 hasConceptScore W3037044462C71924100 @default.
• W3037044462 hasIssue "1" @default.
• W3037044462 hasLocation W30370444621 @default.
• W3037044462 hasLocation W30370444622 @default.
• W3037044462 hasOpenAccess W3037044462 @default.
• W3037044462 hasPrimaryLocation W30370444621 @default.
• W3037044462 hasRelatedWork W10414013 @default.
• W3037044462 hasRelatedWork W12061587 @default.
• W3037044462 hasRelatedWork W13595989 @default.
• W3037044462 hasRelatedWork W14046417 @default.
• W3037044462 hasRelatedWork W3474531 @default.
• W3037044462 hasRelatedWork W3865787 @default.
• W3037044462 hasRelatedWork W4300188 @default.
• W3037044462 hasRelatedWork W5454951 @default.

• next